GW-842,166X
id:
gw-842-166x-198-11008907
title:
GW-842,166X
text:
GW-842,166X is a drug which acts as a potent and selective cannabinoid CB2 receptor agonist, with a novel chemical structure based on a pyrimidine core. It has potent analgesic, anti-inflammatory and anti-hyperalgesic actions in animal models, but without cannabis-like behavioural effects due to its extremely low affinity for the CB1 receptor. GSK brought this compound for into 4 clinical trials, two of them related to pain management and the other two related to bio-distributions. The trials we
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/GW-842,166X
date created:
date modified:
2024-02-03T22:11:11Z
main entity:
{"identifier":"Q5514863","url":"https://www.wikidata.org/entity/Q5514863"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/ce/GW-842%2C166X_Structure.svg","width":116,"height":146}
fields total:
13
integrity:
15